Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Surgalign stock | $0.97

Learn how to easily invest in Surgalign stock.

Surgalign Holdings Inc is a medical devices business based in the US. Surgalign shares (SRGA) are listed on the NASDAQ and all prices are listed in US Dollars. Surgalign employs 197 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Surgalign

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SRGA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Surgalign stock price (NASDAQ: SRGA)

Use our graph to track the performance of SRGA stocks over time.

Surgalign shares at a glance

Information last updated 2021-10-17.
Latest market close$0.97
52-week range$0.89 - $3.27
50-day moving average $1.26
200-day moving average $1.43
Wall St. target price$3.14
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.10

Buy Surgalign shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Surgalign stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Surgalign price performance over time

Historical closes compared with the close of $0.97 from 2021-10-22

1 week (2021-10-15) -2.02%
1 month (2021-09-24) -25.95%
3 months (2021-07-23) -9.35%
6 months (2021-04-23) -50.76%
1 year (2020-10-23) -50.51%
2 years (2019-10-23) -65.60%
3 years (2018-10-23) 4.64
5 years (2016-10-21) 3.11

Is Surgalign under- or over-valued?

Valuing Surgalign stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Surgalign's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Surgalign's EBITDA

Surgalign's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.6 million.

The EBITDA is a measure of a Surgalign's overall financial performance and is widely used to measure a its profitability.

Surgalign financials

Revenue TTM $102.2 million
Gross profit TTM $61.2 million
Return on assets TTM -12.63%
Return on equity TTM -348.23%
Profit margin -8.55%
Book value $0.38
Market capitalisation $138.5 million

TTM: trailing 12 months

Shorting Surgalign shares

There are currently 6.0 million Surgalign shares held short by investors – that's known as Surgalign's "short interest". This figure is 5.1% down from 6.3 million last month.

There are a few different ways that this level of interest in shorting Surgalign shares can be evaluated.

Surgalign's "short interest ratio" (SIR)

Surgalign's "short interest ratio" (SIR) is the quantity of Surgalign shares currently shorted divided by the average quantity of Surgalign shares traded daily (recently around 3.3 million). Surgalign's SIR currently stands at 1.8. In other words for every 100,000 Surgalign shares traded daily on the market, roughly 1800 shares are currently held short.

However Surgalign's short interest can also be evaluated against the total number of Surgalign shares, or, against the total number of tradable Surgalign shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Surgalign's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Surgalign shares in existence, roughly 40 shares are currently held short) or 0.0486% of the tradable shares (for every 100,000 tradable Surgalign shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Surgalign.

Find out more about how you can short Surgalign stock.

Surgalign share dividends

We're not expecting Surgalign to pay a dividend over the next 12 months.

Surgalign share price volatility

Over the last 12 months, Surgalign's shares have ranged in value from as little as $0.89 up to $3.27. A popular way to gauge a stock's volatility is its "beta".

SRGA.US volatility(beta: 2.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surgalign's is 2.2513. This would suggest that Surgalign's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Surgalign overview

Surgalign Holdings, Inc. , a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2. 0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force.

Frequently asked questions

What percentage of Surgalign is owned by insiders or institutions?
Currently 11.802% of Surgalign shares are held by insiders and 49.147% by institutions.
How many people work for Surgalign?
Latest data suggests 197 work at Surgalign.
When does the fiscal year end for Surgalign?
Surgalign's fiscal year ends in December.
Where is Surgalign based?
Surgalign's address is: 520 Lake Cook Road, Deerfield, IL, United States, 60015
What is Surgalign's ISIN number?
Surgalign's international securities identification number is: US86882C1053

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site